Caterina Bartolacci

717 total citations
15 papers, 345 citations indexed

About

Caterina Bartolacci is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Caterina Bartolacci has authored 15 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Caterina Bartolacci's work include Sirtuins and Resveratrol in Medicine (3 papers), Cancer, Lipids, and Metabolism (3 papers) and RNA Interference and Gene Delivery (3 papers). Caterina Bartolacci is often cited by papers focused on Sirtuins and Resveratrol in Medicine (3 papers), Cancer, Lipids, and Metabolism (3 papers) and RNA Interference and Gene Delivery (3 papers). Caterina Bartolacci collaborates with scholars based in Italy, United States and Switzerland. Caterina Bartolacci's co-authors include Cristina Andreani, Cristina Marchini, Augusto Amici, Pier Paolo Scaglioni, Manuela Iezzi, Valentina Gambini, Martina Tilio, Stefania Pucciarelli, María Zabaleta and Junbiao Wang and has published in prestigious journals such as Applied Physics Letters, Scientific Reports and Biochemical Pharmacology.

In The Last Decade

Caterina Bartolacci

15 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caterina Bartolacci Italy 11 224 78 77 48 32 15 345
Cristina Andreani Italy 12 330 1.5× 126 1.6× 99 1.3× 53 1.1× 65 2.0× 20 494
Mengchuan Wang China 13 274 1.2× 106 1.4× 175 2.3× 60 1.3× 5 0.2× 22 472
Yue Shang China 13 292 1.3× 91 1.2× 55 0.7× 24 0.5× 10 0.3× 39 487
Po-Hsien Huang Taiwan 13 460 2.1× 139 1.8× 106 1.4× 39 0.8× 13 0.4× 30 639
Shijie Fan China 12 299 1.3× 96 1.2× 69 0.9× 42 0.9× 9 0.3× 31 518
Nameeta Mujumdar United States 9 425 1.9× 82 1.1× 105 1.4× 11 0.2× 14 0.4× 14 602
Gaoxiang Zhao China 12 355 1.6× 50 0.6× 139 1.8× 28 0.6× 5 0.2× 23 511
Elin Lindhagen Sweden 14 245 1.1× 138 1.8× 67 0.9× 35 0.7× 12 0.4× 28 505
Cecilie Abildgaard Denmark 12 411 1.8× 140 1.8× 202 2.6× 40 0.8× 15 0.5× 17 575
Annick Notte Belgium 6 268 1.2× 92 1.2× 185 2.4× 30 0.6× 25 0.8× 6 475

Countries citing papers authored by Caterina Bartolacci

Since Specialization
Citations

This map shows the geographic impact of Caterina Bartolacci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caterina Bartolacci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caterina Bartolacci more than expected).

Fields of papers citing papers by Caterina Bartolacci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caterina Bartolacci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caterina Bartolacci. The network helps show where Caterina Bartolacci may publish in the future.

Co-authorship network of co-authors of Caterina Bartolacci

This figure shows the co-authorship network connecting the top 25 collaborators of Caterina Bartolacci. A scholar is included among the top collaborators of Caterina Bartolacci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caterina Bartolacci. Caterina Bartolacci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Galassi, Rossana, et al.. (2024). Anticancer Activity of Imidazolyl Gold(I/III) Compounds in Non-Small Cell Lung Cancer Cell Lines. Pharmaceuticals. 17(9). 1133–1133. 1 indexed citations
2.
Andreani, Cristina, Caterina Bartolacci, Francesca Casciaro, et al.. (2023). SIRT6 promotes metastasis and relapse in HER2-positive breast cancer. Scientific Reports. 13(1). 22000–22000. 11 indexed citations
3.
Andreani, Cristina, Caterina Bartolacci, & Pier Paolo Scaglioni. (2022). Ferroptosis: A Specific Vulnerability of RAS-Driven Cancers?. Frontiers in Oncology. 12. 923915–923915. 13 indexed citations
4.
Bartolacci, Caterina, et al.. (2021). Lipid Metabolism Regulates Oxidative Stress and Ferroptosis in RAS-Driven Cancers: A Perspective on Cancer Progression and Therapy. Frontiers in Molecular Biosciences. 8. 706650–706650. 51 indexed citations
5.
Andreani, Cristina, Caterina Bartolacci, Michele Guescini, et al.. (2018). Combination of Coenzyme Q10 Intake and Moderate Physical Activity Counteracts Mitochondrial Dysfunctions in a SAMP8 Mouse Model. Oxidative Medicine and Cellular Longevity. 2018(1). 8936251–8936251. 27 indexed citations
6.
Gambini, Valentina, Martina Tilio, Cristina Andreani, et al.. (2018). In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancer. European Journal of Medicinal Chemistry. 155. 418–427. 20 indexed citations
7.
Bartolacci, Caterina, Cristina Andreani, Claudia Curcio, et al.. (2018). Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer. Cancer Immunology Research. 6(12). 1486–1498. 28 indexed citations
8.
Bartolacci, Caterina, Cristina Andreani, Augusto Amici, & Cristina Marchini. (2018). Walking a Tightrope: A Perspective of Resveratrol Effects on Breast Cancer. Current Protein and Peptide Science. 19(3). 311–322. 10 indexed citations
9.
Bartolacci, Caterina, et al.. (2017). Fatty Acid Synthase Is a Therapeutic Target in Mutant KRAS Lung Cancer. Journal of Thoracic Oncology. 12(8). S1538–S1538. 5 indexed citations
10.
Andreani, Cristina, Caterina Bartolacci, Rita Crinelli, et al.. (2017). Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor. Aging. 9(2). 508–523. 40 indexed citations
11.
Palchetti, Sara, Daniela Pozzi, Cristina Marchini, et al.. (2016). Manipulation of lipoplex concentration at the cell surface boosts transfection efficiency in hard-to-transfect cells. Nanomedicine Nanotechnology Biology and Medicine. 13(2). 681–691. 28 indexed citations
12.
Tilio, Martina, Valentina Gambini, Junbiao Wang, et al.. (2016). Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib. Cancer Letters. 381(1). 76–84. 20 indexed citations
13.
Montani, Maura, Cristina Marchini, Cristina Andreani, et al.. (2015). Getting the most from gene delivery by repeated DNA transfections. Applied Physics Letters. 106(23). 7 indexed citations
14.
Gambini, Valentina, Stefania Pucciarelli, Martina Tilio, et al.. (2014). Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition. Biochemical Pharmacology. 90(3). 226–234. 57 indexed citations
15.
Bartolacci, Caterina, et al.. (2013). Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signaling. Cellular Signalling. 26(2). 352–362. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026